Canada markets closed

Alpha Cognition Inc. (ACOGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5200+0.0200 (+4.00%)
At close: 11:03AM EDT
Full screen
Loading interactive chart...
  • Business Wire

    Alpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

    VANCOUVER, British Columbia, April 04, 2024--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) ("Alpha Cognition," or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended 2023 and provided a corporate update.

  • GlobeNewswire

    Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now

    MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani

  • Business Wire

    Alpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EDT.

    VANCOUVER, British Columbia, March 20, 2024--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that it will present at the Emerging Growth Conference on April 3, 2024. The company invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.